Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Soluble Oncostatin M (OSM), a potential therapeutic target in inflammatory disease, is known to modulate both thrombo- and erythropoiesis. An investigational anti-OSM antibody exhibited reversible thrombocytopenia and anemia in early clinical trials with a short duration of dosing. WHAT QUESTION DID THIS STUDY ADDRESS?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
